home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Revolution Medicines Announces Pricing of Initial Public Offering
Revolution Medicines Announces Pricing of Initial Public Offering
Post navigation
Previous Post
Previous
Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor
Next Post
Next
Blueprint Medicines Reports Fourth Quarter and Full Year 2019 Financial Results